Accretive Health (AH) Tops Q4 EPS Views; Issues Slightly Light Outlook for FY12
Tweet
Share
E-mailGet Alerts AH Hot Sheet
Join SI Premium – FREE
Accretive Health (NYSE: AH) reported Q4 EPS of $0.44, versus the analyst estimate of $0.16. Revenue for the quarter came in at $260.1 million versus the consensus estimate of $254.27 million.
Accretive Health sees FY2012 EPS of $0.61-$0.65, versus the consensus of $0.69. Accretive Health sees FY2012 revenue of $1.07-$1.12 billion, versus the consensus of $1.12 billion.
For earnings history and earnings-related data on Accretive Health (AH) click here.
Accretive Health sees FY2012 EPS of $0.61-$0.65, versus the consensus of $0.69. Accretive Health sees FY2012 revenue of $1.07-$1.12 billion, versus the consensus of $1.12 billion.
For earnings history and earnings-related data on Accretive Health (AH) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Walmart (WMT) PT Lowered to $130 at UBS on Investment Narrative's Competing Dynamics
- S&P 500 may pull back before midterms, but Citi says buy the dip
- RenovoRx regains Nasdaq minimum bid price compliance
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
